scPharmaceuticals Inc.

Historical 13F Holders

Symbol
SCPH
CUSIP
810648105
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 810648105 since 12/18/2024, newest first.

Filer % of Class Filed
Weiss Asset Management LP 13G/A Amendment 1
0% 2/11/2026
Event 12/31/2025
Lytton Laurence W 13G/A Amendment 2 0% 11/14/2025
Event 9/30/2025
Weiss Asset Management LP 13G
5.4% 11/12/2025
Event 9/30/2025
Orin Hirschman 13G/A Amendment 4
0% 11/10/2025
Event 9/30/2025
Tudor Investment Corp Et Al 13G
0% 10/14/2025
Event 10/6/2025
King Luther Capital Management Corp 13G/A Amendment 7
4.0% 10/8/2025
Event 9/30/2025
Glazer Capital, LLC 13G
4.6% 9/10/2025
Event 9/2/2025
King Luther Capital Management Corp 13G/A Amendment 6
7.0% 7/21/2025
Event 6/30/2025
King Luther Capital Management Corp 13G/A Amendment 5
6.5% 4/28/2025
Event 3/31/2025
Orin Hirschman 13G/A Amendment 3
8.4% 1/31/2025
Event 12/31/2024
King Luther Capital Management Corp 13G/A Amendment 4
6.0% 1/28/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 121 41.0 M $233 M
2025 Q2 105 38.7 M $148 M
2025 Q1 92 37.5 M $98.7 M
2024 Q4 90 39.8 M $141 M
2024 Q3 100 37.3 M $170 M
2024 Q2 83 28.0 M $122 M
2024 Q1 85 27.1 M $136 M
2023 Q4 89 28.2 M $177 M
2023 Q3 79 29.9 M $213 M
2023 Q2 88 28.5 M $291 M
2023 Q1 68 24.6 M $223 M
2022 Q4 65 21.4 M $154 M
2022 Q3 43 14.0 M $91.3 M
2022 Q2 39 15.7 M $75.9 M
2022 Q1 38 15.9 M $90.1 M
2021 Q4 34 15.9 M $80.0 M
2021 Q3 32 16.2 M $108 M
2021 Q2 39 16.0 M $97.9 M
2021 Q1 47 17.2 M $114 M
2020 Q4 49 17.0 M $89.9 M
2020 Q3 52 17.1 M $127 M
2020 Q2 52 17.5 M $129 M
2020 Q1 35 12.5 M $92.4 M
2019 Q4 29 11.2 M $63.1 M
2019 Q3 27 7.58 M $44.5 M
2019 Q2 34 7.38 M $23.5 M
2019 Q1 36 7.48 M $22.5 M
2018 Q4 38 7.90 M $29.7 M
2018 Q3 37 8.07 M $47.4 M
2018 Q2 42 8.10 M $45.9 M
2018 Q1 39 8.33 M $103 M
2017 Q4 24 7.81 M $94.4 M